49 related articles for article (PubMed ID: 10792330)
1. Growth hormone plus childhood low-dose estrogen in Turner's syndrome.
Ross JL; Quigley CA; Cao D; Feuillan P; Kowal K; Chipman JJ; Cutler GB
N Engl J Med; 2011 Mar; 364(13):1230-42. PubMed ID: 21449786
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone therapy is associated with improved uterine dimensions in girls with Turner syndrome prior to oestrogen replacement.
Mondal S; Gargari P; Nagendra L; Mandal S; Kumar RC; Shah P; Haldar M; Chowdhury S; Mukhopadhyay S
Clin Endocrinol (Oxf); 2024 Jan; 100(1):66-75. PubMed ID: 37555570
[TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant human growth hormone on changes in height, bone mineral density, and body composition over 1-2 years in children with Hurler or Hunter syndrome.
Polgreen LE; Thomas W; Orchard PJ; Whitley CB; Miller BS
Mol Genet Metab; 2014 Feb; 111(2):101-6. PubMed ID: 24368158
[TBL] [Abstract][Full Text] [Related]
4. Effect of Growth Hormone Treatment on the Concentration of Selected Metabolic Markers in Girls With Turner Syndrome.
Błaszczyk E; Gawlik J; Gieburowska J; Tokarska A; Kimsa-Furdzik M; Hibner G; Francuz T; Gawlik A
Front Endocrinol (Lausanne); 2022; 13():818735. PubMed ID: 35769087
[TBL] [Abstract][Full Text] [Related]
5. Effects of Hormone Replacement Therapy on Bone Mineral Density in Korean Adults With Turner Syndrome.
Kim S; Kim H; Lee I; Choi E; Baek J; Lee J; Kim HR; Yun BH; Choi YS; Seo SK
J Korean Med Sci; 2024 Jan; 39(1):e9. PubMed ID: 38193328
[TBL] [Abstract][Full Text] [Related]
6. Health-Related Quality of Life in Turner Syndrome and the Influence of Growth Hormone Therapy: A 20-Year Follow-Up.
Krantz E; Landin-Wilhelmsen K; Trimpou P; Bryman I; Wide U
J Clin Endocrinol Metab; 2019 Nov; 104(11):5073-5083. PubMed ID: 31009056
[TBL] [Abstract][Full Text] [Related]
7. Adult Height in Indian Girls with Turner Syndrome Treated with Long-Term Growth Hormone Therapy - A Western India Tertiary Centre Experience.
Khadilkar V; Mondkar S; Oza C; Gondhalekar K; Khadilkar A
Indian J Endocrinol Metab; 2023; 27(3):249-254. PubMed ID: 37583400
[TBL] [Abstract][Full Text] [Related]
8. Management of Turner's syndrome in adult life: case-series and systematic review.
Ros C; Castelo-Branco C
Gynecol Endocrinol; 2012 Sep; 28(9):726-32. PubMed ID: 22316390
[TBL] [Abstract][Full Text] [Related]
9. Does ethnicity influence bone health index in children? A pilot study.
Boitsios G; Saliba T; Aparisi Gómez MP; Simoni P
Pediatr Radiol; 2024 Feb; 54(2):316-323. PubMed ID: 38227019
[TBL] [Abstract][Full Text] [Related]
10. Comparison of radiogrammetrical metacarpal indices in children and reference data from the First Zurich Longitudinal Study.
Martin DD; Heckmann C; Neuhof J; Jenni OG; Ranke MB; Binder G
Pediatr Radiol; 2012 Aug; 42(8):982-91. PubMed ID: 22669456
[TBL] [Abstract][Full Text] [Related]
11. The Interplay between Muscular Grip Strength and Bone Mineral Density with Consideration of Metabolic and Endocrine Parameters in Individuals with Turner Syndrome.
Krzyścin M; Gruca-Stryjak K; Soszka-Przepiera E; Syrenicz I; Przepiera A; Cymbaluk-Płoska A; Bumbulienė Ž; Sowińska-Przepiera E
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137346
[TBL] [Abstract][Full Text] [Related]
12. Effects of hypogonadism on bone metabolism in female adolescents and young adults.
Misra M
Nat Rev Endocrinol; 2012 Jan; 8(7):395-404. PubMed ID: 22271187
[TBL] [Abstract][Full Text] [Related]
13. Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial.
Gault EJ; Perry RJ; Cole TJ; Casey S; Paterson WF; Hindmarsh PC; Betts P; Dunger DB; Donaldson MD;
BMJ; 2011 Apr; 342():d1980. PubMed ID: 21493672
[TBL] [Abstract][Full Text] [Related]
14. Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome.
Holroyd CR; Davies JH; Taylor P; Jameson K; Rivett C; Cooper C; Dennison EM
Osteoporos Int; 2010 Dec; 21(12):2093-9. PubMed ID: 20135092
[TBL] [Abstract][Full Text] [Related]
15. Fracture risk and bone mineral density in Turner syndrome.
Bakalov VK; Bondy CA
Rev Endocr Metab Disord; 2008 Jun; 9(2):145-51. PubMed ID: 18415020
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
[TBL] [Abstract][Full Text] [Related]
18. Final height in girls with Turner's syndrome treated with once or twice daily growth hormone injections. Dutch Advisory Group on Growth Hormone.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; Hokken-Koelega AC; Waelkens JJ; Massa GG; Vulsma T; Gerver WJ; Reeser HM; Delemarre-van de Waal HE; Jansen M; Drop SL
Arch Dis Child; 1999 Jan; 80(1):36-41. PubMed ID: 10325756
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
